Global Mid-Size Pharmaceutical Market 2016-2018 & 2021: Market is Projected to Grow from Approximately $1.1 Trillion in 2016 to $1.5 Trillion in 2021
Summary
Growth will be driven by global demographic and economic trends, including a rapidly aging global population and an associated rise in chronic diseases; increased urbanization; higher disposable income; greater government expenditure on healthcare; and growing demand for more effective treatments.The pharmaceutical sector can be divided into various categories based on revenue, comprising large, mid-size and small pharma companies.Most mid-size pharma companies are focusing heavily on developing a portfolio of generic products covering a variety of therapy areas and geographies.Additionally, the top mid-size companies are involved in the end-to-end development of innovative products, although in these cases their focus is limited to specific therapy areas.Mid-size Pharma Companies - Growth Strategies related to Deals and Collaborations Mergers and Acquisitions Licensing Agreements and Partnerships R&D Collaboration Geographical Expansion In-House Research and Development Shift towards High-Value Generics from Low-Value Generics Brand Building Specialized Therapy Areas and Rare Diseases